2. Academic Validation
  3. Novel Azepinoindole Compounds as 5‑HT2A Agonists for Treating Neuropsychiatric and Neurodegenerative Disorders

Novel Azepinoindole Compounds as 5‑HT2A Agonists for Treating Neuropsychiatric and Neurodegenerative Disorders

  • ACS Med Chem Lett. 2025 Oct 20;16(11):2181-2182. doi: 10.1021/acsmedchemlett.5c00613.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
PMID: 41256984 DOI: 10.1021/acsmedchemlett.5c00613
Abstract

Provided herein are novel azepinoindole compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating neuropsychiatric and neurodegenerative disorders, and processes for preparing such compounds.

Figures
Products